As of Jul 02
| +0.08 / +0.51%|
The 6 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 18.00, with a high estimate of 33.00 and a low estimate of 5.00. The median estimate represents a +14.00% increase from the last price of 15.79.
The current consensus among 7 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.